Mphetas 500 mg tablets contain mycophenolate mofetil, which is a medication used to prevent the body from rejecting transplanted organs such as kidneys, heart, or liver. It is an immunosuppressive agent that works by slowing down the production of white blood cells that attack transplanted organs.
Mycophenolate mofetil comes in the form of tablets, capsules, or an oral suspension, and is available only by prescription. The dosage and frequency of administration may vary depending on the patient’s age, weight, and individual response to the medication.
The tablets and capsules are usually taken orally, with or without food, and swallowed whole. The oral suspension is usually taken on an empty stomach, and should be shaken well before use. Patients should follow the instructions provided by their healthcare provider carefully.
Mycophenolate mofetil is typically used in combination with other medications, such as corticosteroids and cyclosporine. Patients should discuss potential risks and benefits with their healthcare provider before starting treatment with mycophenolate mofetil, as there are potential side effects associated with the medication, including diarrhea, nausea, vomiting, abdominal pain, and increased risk of infection.
In summary, mycophenolate mofetil is an important medication for preventing organ rejection in transplant patients, and should only be used under the guidance and supervision of a healthcare professional.
